Digital Evidence, Real Reimbursement: DTx & RPM After the Codes

The digital health industry has reached a turning point: new RPM and RTM billing codes are live, payers have expanded coverage frameworks, and regulators are signaling long-term support for virtual-first and software-based care models. Yet despite these policy wins, widespread adoption remains uneven. Many organizations are still struggling to translate regulatory green lights into revenue, outcomes, and repeatable operational success.

This discussion examines what it takes to move digital reimbursement from theory to reality. How are innovators converting digital encounters into billable, compliant, and scalable services? What infrastructure — from documentation to audit readiness — is required to satisfy payer scrutiny while maintaining clinical integrity? And where are the bright spots that demonstrate that digital medicine can deliver both health and financial returns?

Participants will explore real-world examples of digital therapeutics and remote patient monitoring programs that have achieved measurable success — and analyze what distinguishes sustainable reimbursement models from pilots that stall.

Join us to discuss:

• How are innovators translating RPM and RTM codes into scalable cash flow and clinical results?

• What audit and compliance challenges are emerging as digital reimbursement matures?

• Which business models best align clinical impact with sustainable payment pathways?